Laidlaw Venture Partners will primarily focus on funding healthcare companies at various stages of development.
We will consider companies in any geography and therapeutic area. Our goal is to work with a select group of companies with novel products/platforms which address unmet medical needs, in attractive commercial markets. We work with several companies each year that, when partnered with our capital markets, strategic and advisory capabilities, will maximize corporate value.
Our skills and network allow us to focus on novel therapeutics as well as on relatively low risk technologies and platforms. This could include preclinical programs, earlier stage programs in drug reformulation, med tech, etc.